ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2016 American Transplant Congress

    Reduced CMV Infection Using Single Low-Dose of Rabbit Anti-Thymocyte Globulin in Kidney Transplanted Recipients.

    M. Paula, C. Felipe, M. Cristelli, P. Orlandi, L. Viana, G. Basso, P. Carvalho, C. Montenegro, A. Lima, I. Pietrobom, H. Tedesco-Silva, J. Medina-Pestana.

    Hospital do Rim - UNIFESP, Sao Paulo, Brazil.

    BACKGROUND: Cytomegalovirus (CMV) infection is associated with significant morbidity and mortality after solid organ transplantation and the historic incidence of our institution was 77%. Aiming…
  • 2016 American Transplant Congress

    Managing the Kidney Waiting List: Pride and Prejudice.

    F. Smith,1 C. Sheehan,1 A. Farney,1 J. Rogers,1 G. Orlando,1 A. Reeves-Daniel,2 A. Palanisamy,2 R. Stratta.1

    1Surgery, Wake Forest, Winston-Salem, NC; 2Internal Medicine, Wake Forest, Winston-Salem, NC.

    Management of the kidney waiting list (WL) is an essential and dynamic aspect of the pretransplant process; however, it remains under-studied and underappreciated. The study…
  • 2016 American Transplant Congress

    Ineligible: Attitudes and Follow-Up of Individuals Ruled Out of Living Kidney Donation.

    D. Dobosz,1 C. Thiessen,1 J. Gannon,1 S. Li,1 K. Kennedy,2 D. Gray,3 A. Mussell,3 E. Gordon,2 S. Kulkarni,1 P. Reese.3

    1Yale U, New Haven; 2Northwestern U, Chicago; 3U Pennsylvania, Philadelphia.

    Background: Little is known about the experiences of individuals who begin living kidney donor (LKD) evaluation but are turned down due to ineligibility. We assessed…
  • 2016 American Transplant Congress

    Influence of Cold Ischemia Time in Kidney Transplants from Small Pediatric Donors.

    L. Kayler,1 M. Lubetzky,2 P. Friedman.3

    1Erie County Medical Center, Buffalo; 2Montefiore Medical Center, Bronx; 3Montefiore Medical Center, Bronx.

    Clinicians may be reluctant to transplant small pediatric kidneys that also have prolonged cold ischemia time (CIT) for fear of an additional deleterious effect since…
  • 2016 American Transplant Congress

    Wound Healing Complications in Kidney Transplant Recipients Receiving Everolimus.

    P. Ueno,1 H. Tedesco,1 A. Brigido,1 C. Felipe,1 P. Hannun,1 M. Cristelli,1 W. Aguiar,2 J. Medina-Pestana.1

    1Nephrology Division, Hospital do Rim - UNIFESP, Sao Paulo, Brazil; 2Urology Division, Hospital do Rim, Sao Paulo, Brazil.

    Background: Regimens with de novo everolimus (EVR) are associated with a concentration-dependent incidence of wound healing adverse events (WHAE), but mycophenolate use also is related…
  • 2016 American Transplant Congress

    Relationship Between Dialisys Duration and Prevalence of Cardiovascular Diseases in Kidney Transplantation Recipients.

    K. Unagami,1 M. Okumi,2 T. Hirai,2 Y. Okabe,3 K. Masutani,4 T. Shimizu,2 K. Omoto,2 M. Inui,2 H. Ishida,2 T. Kitazono,4 K. Nitta,1 K. Tanabe,2 The Japan Academic Consortium of Kidney Transplantation (JACK).

    1Nephrology, Tokyo Women's Medical University, Tokyo, Japan; 2Urology, Tokyo Women's Medical University, Tokyo, Japan; 3Surgery, Kyushu University, Fukuoka, Japan; 4Medicine and Clinical Science, Kyushu University, Fukuoka, Japan.

    Background: Among kidney transplantation (KTx) recipients, the prevalence of Cardiovascular disease (CVD) is high. However, to our knowledge, the relationship between the prevalence of CVD…
  • 2016 American Transplant Congress

    Parainfluenza-3 Infections Early After Kidney Transplantation.

    I. Helanterä,1 V.-J. Anttila,2 M. Lempinen.1

    1Transplantation and Liver Surgery, Helsinki University Hospital, Helsinki, Finland; 2Department of Infectious Diseases, Helsinki University Hospital, Helsinki, Finland.

    A. Purpose: Parainfluenza (PIV) is able to cause serious and even fatal infections after hematopoietic stem cell and lung transplantation. Limited data are available about…
  • 2016 American Transplant Congress

    Role of Preformed IgM Donor Human Leucocyte Antigen (HLA) Specific Antibodies in HLA Incompatible Renal Transplantation.

    A. Andreou, A. Babu, T. Barber, R. Higgins, D. Briggs, D. Mitchell, N. Khovanova, T. Shaikhina, S. Daga.

    Renal, University Hospitals Coventry and Wawickshire, Coventry, United Kingdom; Life Sciences, University of Warwick, Coventry, United Kingdom; School of Mathematics and Engineering, University of Warwick, Coventry, United Kingdom.

    Introduction: Pre-transplant IgG antibody screening is common due to its established role of predicting rejection and graft survival; the role of pre-formed IgM human leukocyte…
  • 2016 American Transplant Congress

    Memory Regulatory T Cell: A Potential Actor in Immunological Operational Tolerance in Kidney-Transplant Patients via the ATP Degradation into Adenosine.

    M. Durand,1,2 F. Braza,1 N. Degauque,1 F. Dubois,2 M. Chesneau,1 P. Guérif,1,3 M. Giral,1,3 S. Brouard.1

    1ITUN-INSERM U1064, Nantes, France; 2University of Nantes, Nantes, France; 3Biotherapy Clinical Investigation Center, Nantes, France.

    Regulatory T cells (Tregs) are essential actors in the control of self-tolerance and exacerbated inflammation. In experimental transplantation Tregs are critical to achieve alloantigen tolerance…
  • 2016 American Transplant Congress

    Outcomes in Black vs Non-Black Patients Administered Belatacept (Bela) or Cyclosporine (CsA) in BENEFIT-EXT.

    S. Florman,1 A. Durrbach,2 V. Duro Garcia,3 K. Calderon,4 U. Meier-Kriesche,4 M. Polinsky,4 H. Zhao,4 J. Medina Pestana.5

    1Mount Sinai Med Ctr, New York; 2Univ Hôpital of Bicêtre, Le Kremlin-Bicêtre, France; 3Hosp Dom Vicente Scherer, Porto Alegre, Brazil; 4BMS, Lawrenceville; 5Hosp do Rim, Sao Paulo, Brazil.

    Studies consistently show worse outcomes for black vs non-black kidney transplant recipients. At 7 yrs post-transplant in BENEFIT-EXT (NCT00114777), bela was associated with similar graft…
  • « Previous Page
  • 1
  • …
  • 406
  • 407
  • 408
  • 409
  • 410
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences